Liposomal Bupivacaine (Exparel ® ) Plus 0.5% Bupivacaine HCL Versus 0.5% Bupivacaine HCL for Interscalene Nerve Block (ISB) for Patients Undergoing Total Shoulder Arthroplasty(TSA)
Clinical trial NCT03913091 · COMPLETED
Trial details
- NCT number
- NCT03913091
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2021-01-19
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.